Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (161-170 of 365) with videos related to

Pageof 37
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 22, 2026
Impact of plasma pTau181 levels on clinician diagnostic confidence and management in memory and cognition clinics: A multi-site before-and-after studyJohannes C Michaelian, Azadeh Feizpour, James C Vickers, et al.
Brain : a Journal of Neurology|February 12, 2011
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's diseaseGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 19, 2019
Comparison of <sup>18</sup>F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL<sup>®</sup> approaches: Validation against histopathologyVincent Doré, Santiago Bullich, Christopher C Rowe, et al.
Alzheimer'S Research & Therapy|February 28, 2014
Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathiesMichelle T Fodero-Tavoletti, Shozo Furumoto, Leanne Taylor, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2011
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0David S W Djang, Marcel J R Janssen, Nicolaas Bohnen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 23, 2016
Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohortEster Cerin, Stephanie R Rainey-Smith, David Ames, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 14, 2022
Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility studyPriscilla Gates, Meinir Krishnasamy, Carlene Wilson, et al.
The British Journal of Nutrition|September 19, 2015
Comparative analysis of the Cancer Council of Victoria and the online Commonwealth Scientific and Industrial Research Organisation FFQSamantha L Gardener, Stephanie R Rainey-Smith, S Lance Macaulay, et al.
Alzheimer'S Research & Therapy|March 6, 2020
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's diseaseSanka Amadoru, Vincent Doré, Catriona A McLean, et al.
Frontiers in Aging Neuroscience|December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle StudySamantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Pageof 37

Showing results (161-170 of 365) with videos related to

Sort By:
Pageof 37
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 22, 2026
Impact of plasma pTau181 levels on clinician diagnostic confidence and management in memory and cognition clinics: A multi-site before-and-after studyJohannes C Michaelian, Azadeh Feizpour, James C Vickers, et al.
Brain : a Journal of Neurology|February 12, 2011
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's diseaseGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 19, 2019
Comparison of <sup>18</sup>F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL<sup>®</sup> approaches: Validation against histopathologyVincent Doré, Santiago Bullich, Christopher C Rowe, et al.
Alzheimer'S Research & Therapy|February 28, 2014
Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathiesMichelle T Fodero-Tavoletti, Shozo Furumoto, Leanne Taylor, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2011
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0David S W Djang, Marcel J R Janssen, Nicolaas Bohnen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 23, 2016
Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohortEster Cerin, Stephanie R Rainey-Smith, David Ames, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 14, 2022
Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility studyPriscilla Gates, Meinir Krishnasamy, Carlene Wilson, et al.
The British Journal of Nutrition|September 19, 2015
Comparative analysis of the Cancer Council of Victoria and the online Commonwealth Scientific and Industrial Research Organisation FFQSamantha L Gardener, Stephanie R Rainey-Smith, S Lance Macaulay, et al.
Alzheimer'S Research & Therapy|March 6, 2020
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's diseaseSanka Amadoru, Vincent Doré, Catriona A McLean, et al.
Frontiers in Aging Neuroscience|December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle StudySamantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Pageof 37